Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Terminated 2Unknown 1

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Carcinoma, Non-Small-Cell Lung 3Prostatic Neoplasms 2Polycystic Ovary Syndrome 2Leukoplakia, Oral 2Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene 1Skin Neoplasms 1Pancreatic Neoplasms 1Lung Neoplasms 1Liposarcoma, Myxoid 1Liposarcoma 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Acute 1Insulin Resistance 1Head and Neck Neoplasms 1Carotid Intimal Medial Thickness 1 1Carcinoma, Squamous Cell 1Breast Neoplasms 1

Interventions

Carboplatin 361Pemetrexed 276Cisplatin 230Paclitaxel 213Docetaxel 205Gemcitabine 160Erlotinib Hydrochloride 150Bevacizumab 132pembrolizumab 129Radiotherapy 114Nivolumab 88durvalumab 84Drug Therapy 84osimertinib 82atezolizumab 58Vinorelbine 53Gefitinib 53Radiosurgery 50Cetuximab 39Taxes 37130-nm albumin-bound paclitaxel 36Ipilimumab 34anlotinib 33Surgical Procedures, Operative 33Magnetic Resonance Spectroscopy 33Etoposide 30Albumin-Bound Paclitaxel 29tislelizumab 27icotinib 27aflutinib 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Carcinoma, Non-Small-Cell Lung × Pioglitazone × Clear all
NCT02852083 2018-01-18

ModuLung

University Hospital Regensburg

Phase 2 Unknown
86 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01342770 2017-12-05

Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 2 Terminated
6 enrolled 12 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00923949 2015-09-30

Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
1 enrolled 7 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡